This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Two years after filing, specialty pharmaco Cumberland Pharmaceuticals has completed its initial public offering, netting $79mm through the sale of 5mm shares at $17. (The company had originally planned to sell 6.25mm shares priced between $14 and $16 each, but last month in an amended S-1 filing it dropped the number of shares to 5mm and upped the target price to between $19 and $21.)
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?